These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6377685)

  • 41. Evidence that medium-chain fatty acid oxidation can support an active gluconeogenesis in the suckling newborn rat.
    Turlan P; Ferre P; Girard JR
    Biol Neonate; 1983; 43(1-2):103-8. PubMed ID: 6850010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatic carnitine palmitoyltransferase turnover and translation.
    Nutr Rev; 1988 Apr; 46(4):171-2. PubMed ID: 3285253
    [No Abstract]   [Full Text] [Related]  

  • 43. Mechanisms of the glucose lowering effect of a carnitine palmitoyl transferase inhibitor in normal and diabetic rats.
    Martin C; Odeon M; Cohen R; Beylot M
    Metabolism; 1991 Apr; 40(4):420-7. PubMed ID: 2011084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiketogenic and hypoglycemic effects of aminocarnitine and acylaminocarnitines.
    Jenkins DL; Griffith OW
    Proc Natl Acad Sci U S A; 1986 Jan; 83(2):290-4. PubMed ID: 3455765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ketogenesis: mechanism, regulation, metabolic repercussions].
    Assan R
    Pathol Biol (Paris); 1970 May; 18(9):507-20. PubMed ID: 4912162
    [No Abstract]   [Full Text] [Related]  

  • 46. Enhancement of mitochondrial carnitine and carnitine acylcarnitine translocase-mediated transport of fatty acids into liver mitochondria under ketogenic conditions.
    Parvin R; Pande SV
    J Biol Chem; 1979 Jun; 254(12):5423-9. PubMed ID: 447661
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of the fatty acid oxidation inhibitor 2-tetradecylglycidic acid (TDGA) on glucose and fatty acid oxidation in isolated rat soleus muscle.
    Tuman RW; Joseph JM; Brentzel HJ; Tutwiler GF
    Int J Biochem; 1988; 20(2):155-60. PubMed ID: 3350201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2-Tetradecylglycidic acid.
    Tutwiler GF; Ho W; Mohrbacher RJ
    Methods Enzymol; 1981; 72():533-51. PubMed ID: 7311851
    [No Abstract]   [Full Text] [Related]  

  • 49. Studies on fatty acid omega-oxidation. Antiketogenic effect and gluconeogenicity of dicarboxylic acids.
    Wada F; Usami M
    Biochim Biophys Acta; 1977 May; 487(2):361-8. PubMed ID: 861239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emeriamine, an antidiabetic beta-aminobetaine derived from a novel fungal metabolite.
    Kanamaru T; Shinagawa S; Asai M; Okazaki H; Sugiyama Y; Fujita T; Iwatsuka H; Yoneda M
    Life Sci; 1985 Jul; 37(3):217-23. PubMed ID: 3839282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of leptin expression by an inhibitor of carnitine palmitoyltransferase-1.
    Wolkowicz P; Grenett H; Belousova M; Urthaler F
    Int J Obes Relat Metab Disord; 2004 Apr; 28(4):649-51. PubMed ID: 14758344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclooxygenase inhibition up-regulates liver carnitine palmitoyltransferase 1A expression and improves fatty liver.
    Rosselli MS; Burgueño AL; Pirola CJ; Sookoian S
    Hepatology; 2011 Jun; 53(6):2143-4; author reply 2145-6. PubMed ID: 21433038
    [No Abstract]   [Full Text] [Related]  

  • 53. Hormonal and nutritional control of liver fatty acid oxidation and ketogenesis during development.
    Prip-Buus C; Thumelin S; Chatelain F; Pegorier JP; Girard J
    Biochem Soc Trans; 1995 Aug; 23(3):500-6. PubMed ID: 8566401
    [No Abstract]   [Full Text] [Related]  

  • 54. Contribution of hepatic fatty acid oxidation and exogenous galactose supply to the regulation of glucose homeostasis in the newborn rabbit.
    Pégorier JP; Duée PH; Girard JR
    Biol Neonate; 1987; 51(1):31-9. PubMed ID: 3828415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Restoration of glucose utilization in alloxan diabetes by means of inhibiting fatty acid oxidation and gluconeogenesis].
    Kendysh IN
    Probl Endokrinol (Mosk); 1978; 24(5):73-6. PubMed ID: 704562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Decreased oxidation of ketone bodies by heart mitochondria in diabetes].
    Grinblat L; Stoppani AO
    Medicina (B Aires); 1986; 46(6):698-704. PubMed ID: 3626838
    [No Abstract]   [Full Text] [Related]  

  • 57. Carnitine palmitoyltransferase modulation of hepatic fatty acid metabolism and radio-HPLC evidence for low ketogenesis in neonatal pigs.
    Odle J; Lin X; van Kempen TA; Drackley JK; Adams SH
    J Nutr; 1995 Oct; 125(10):2541-9. PubMed ID: 7562089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the oral hypoglycemic agent 2-tetradecylglycidic acid on fatty acid oxidation in suckling rats in vivo and in perfused liver.
    Frost SC; Wells MA
    Arch Biochem Biophys; 1981 Oct; 211(2):547-55. PubMed ID: 7305389
    [No Abstract]   [Full Text] [Related]  

  • 59. On the occurrence of enzymes of ketone-body metabolism in human adipose tissue.
    Rous S
    Biochem Biophys Res Commun; 1976 Mar; 69(1):74-8. PubMed ID: 4072
    [No Abstract]   [Full Text] [Related]  

  • 60. Evidence for the involvement of carnitine-dependent long-chain acyltransferases in neuronal triglyceride and phospholipid fatty acid turnover.
    Arduini A; Denisova N; Virmani A; Avrova N; Federici G; Arrigoni-Martelli E
    J Neurochem; 1994 Apr; 62(4):1530-8. PubMed ID: 8133280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.